XML 46 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
[1]
Subscription Receivable
Cumulative Translation Adjustment
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021 [1]   4,086,534        
Beginning balance at Dec. 31, 2021 $ 212,423 $ 0 [1] $ 281,819 $ 0 $ 0 $ (69,396)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 2,636   2,636      
Issuance of shares, net of issuance costs (in shares) [1]   489,576        
Issuance of shares, net of issuance costs 9,532   9,532      
Restricted shares award issuance, net of withholdings (in shares) [1]   48,938        
Restricted shares award issuance, net of withholdings (227)   (227)      
Shares issued in connection with equity exchange agreement 0          
Proceeds from stock options exercised (in shares) [1]   230        
Proceeds from stock options exercised 14   14      
Foreign currency translation adjustment (357)       (357)  
Warrant issued in exchange for warrant asset 0          
Net loss (271,068)         (271,068)
Ending balance (in shares) at Dec. 31, 2022 [1]   4,625,278        
Ending balance at Dec. 31, 2022 (47,047) $ 0 [1] 293,774 0 (357) (340,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 2,344   2,344      
Issuance of shares, net of issuance costs (in shares) [1]   4,144,419        
Issuance of shares, net of issuance costs 20,831 $ 1 [1] 21,528 (698)    
Reverse stock split fractional share adjustment (in shares) [1]   34,538        
Restricted shares award issuance, net of withholdings (in shares) [1]   13,684        
Issuance of shares for amendment fee associated with debt modification (Note 6) (in shares) [1]   133,333        
Issuance of shares for amendment fee associated with debt modification (Note 6) 1,000   1,000      
Shares issued in connection with equity exchange agreement (in shares) [1]   180,000        
Shares issued in connection with equity exchange agreement 869   869      
Foreign currency translation adjustment 12       12  
Warrant issued in exchange for warrant asset 477   477      
Net loss (29,510)         (29,510)
Ending balance (in shares) at Dec. 31, 2023 [1]   9,131,252        
Ending balance at Dec. 31, 2023 $ (51,024) $ 1 [1] $ 319,992 $ (698) $ (345) $ (369,974)
[1] Retroactively adjusted for the effects of the Reverse Stock Split (see Note 1 — Organization and Description of Business)